Candel Therapeutics, Inc. (CADL) Reports Q2 Loss of $0.74/sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Dow, S&P 500 fall, tech steadies to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude jumps to highest since April on Houthi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| (NASDAQ: CADL) | Delayed: 7.99 -0.39 (4.65%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.38 | 52 Week High | $ | |||
| Open | $8.33 | 52 Week Low | $ | |||
| Day High | $8.33 | P/E | N/A | |||
| Day Low | $7.91 | EPS | $ | |||
| Volume | 772,339 | |||||
